Pain Management in NTOS – Advanced Techniques

Chapter
First Online:

Abstract

When thoracic outlet syndrome (TOS) causes chronic neuropathic pain, or in rare cases causes complex regional pain syndrome (CRPS), a wide variety of advanced therapies can be used to treat the chronic, debilitating pain of neurogenic thoracic outlet syndrome (NTOS). Chronic pain treatment algorithms typically begin with less invasive, reversible therapies and those that have few side effects. Thus, physical therapy and non-narcotic medications are used first, often in conjunction with behavioral therapy. These may be followed by more potent analgesics, nerve blocks, neurostimulation, or medication infusions into the spinal fluid by implantable pumps, and finally by neuroablation. Unlike neuroablation, neurostimulation (spinal cord stimulation, peripheral nerve stimulation, deep brain stimulation, and motor cortex stimulation), intrathecal drug delivery, and ketamine infusions spare nerve tissue and can be reversed or discontinued if necessary. Consistent definitions of pain types by the International Association for the Study of Pain (IASP) have allowed indications for these therapies to be refined. Continuing elucidation of the anatomy, physiology, and psychology of pain, as well as recommendations for best practices, have been the focus of study by The North American Neuromodulation Society and the International Neuromodulation Society. A host of technical advances in equipment also support pain practitioners in managing the pain of NTOS more effectively.

Keywords

Neuropathic Pain Deep Brain Stimulation Carpal Tunnel Syndrome Complex Regional Pain Syndrome Spinal Cord Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Furlan AD, Lui PW, Mailis A. Chemical sympathectomy for neuropathic pain: does it work? Case report and systematic literature review. Clin J Pain. 2001;17(4):327–36.PubMedCrossRefGoogle Scholar
  2. 2.
    North RB, Shipley J. The neuromodulation therapy access coalition. Practice parameters for the use of spinal cord stimulation in the treatment of chronic neuropathic pain. Pain Med. 2007;8:S200–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Oakley JC, Weiner RL. Spinal cord stimulation of complex regional pain syndrome: a prospective study of 19 patients at two centers. Neuromodulation. 1999;2:47–50.PubMedCrossRefGoogle Scholar
  4. 4.
    DeJongste MJL. Spinal cord stimulation for ischemic heart disease. Neurol Res. 2000;22:293–8.PubMedGoogle Scholar
  5. 5.
    Huber SJ, Vaglienti RM, Huber JS. Spinal cord stimulation in severe, inoperable, peripheral vascular ­disease. Neuromodulation. 2000;3:131–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Prager JP, Stanton-Hicks M. Neurostimulation. In: Cousins MJ, Bridenbaugh PO, Carr DB, et al., editors. Cousins and Bridenbaugh’s neural blockade in clinical anesthesia and pain medicine. 4th ed. Philadelphia: Williams & Wilkins; 2010. p. 948–90.Google Scholar
  7. 7.
    Oakley JC. Spinal cord stimulation for the treatment of chronic pain. In: Follett KA, editor. Neurosurgical pain management. Philadelphia: Saunders; 2004. p. 131–44.CrossRefGoogle Scholar
  8. 8.
    Campbell JN, Long DM. Peripheral nerve stimulation in the treatment of intractable pain. J Neurosurg. 1976;45(6):682–9.Google Scholar
  9. 9.
    Levy R. Differentiating the leaves from the branches in the tree of neuromodulation: the state of peripheral nerve field stimulation. Neuromodulation. 2011;14:201–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Stanton-Hicks M, Salamon J. Stimulation of the central and peripheral nervous system for the control of pain. J Clin Neurophysiol. 1997;14(1):46–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Hassenbusch SJ, Stanton-Hicks M, Schoppa D, Walsh JG, Covington EC. Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg. 1996;84:415–23.PubMedCrossRefGoogle Scholar
  12. 12.
    Kupers R, Laere KV, Calenbergh FV, et al. Multimodal therapeutic assessment of peripheral nerve stimulation in neuropathic pain: five case reports with a 20-year follow-up. Eur J Pain. 2011;15(2):161.PubMedGoogle Scholar
  13. 13.
    Deer TR, Levy RM, Rosenfeld EL. Prospective clinical study of a new implantable peripheral nerve stimulation device to treat chronic pain. Clin J Pain. 2010;26(5):359–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Kim HJ, Paek SH, Kim JY, et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol. 2008;255(12):1889–94.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim HJ, Jeon BS, Paek SH. Effect of deep brain stimulation on pain in Parkinson disease. J Neurol Sci. 2011;310(1-2):251–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Kim HJ, Jeon BS, Lee JY, Kim DG. The benefit of subthalamic deep brain stimulation on pain in Parkinson disease: a 2-year follow-up study. Neurosurgery. 2011;70(1):18–23.CrossRefGoogle Scholar
  17. 17.
    Breit S, Schulz JB, Benabid A-L. Deep brain stimulation. Cell Tissue Res. 2004;318(1):275–88.PubMedCrossRefGoogle Scholar
  18. 18.
    Levy R, Deer TR, Henderson J. Intracranial neurostimulation for pain control: a review. Pain Physician. 2010;13:157–65.PubMedGoogle Scholar
  19. 19.
    Levy RM. Deep brain stimulation for the treatment of intractable pain. Neurosurg Clin N Am. 2003;14(3):389–99, vi.PubMedCrossRefGoogle Scholar
  20. 20.
    Fontaine D, Hamani C, Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg. 2009;110:251–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Nuti C, Peyron R, Garcia-Larrea L, et al. Motor cortex stimulation for neuropathic pain: four year outcome and predictors of efficacy. Pain. 2005;228:43–52.CrossRefGoogle Scholar
  22. 22.
    Prager J, Bruel B, Buchser E, Caraway D, Cousins M, Deer T, et al. Best practices for intrathecal drug delivery. Neuromodulation. 2013 (in press).Google Scholar
  23. 23.
    Prager J. Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin. Spine. 2002;27(22):2593–605.PubMedCrossRefGoogle Scholar
  24. 24.
    Hassenbusch SJ, Portenoy RK, Cousins M, et al. Polyanalgesic consensus conference 2003: an update on the management of pain by intraspinal drug delivery – report of an expert panel. J Pain Symptom Manage. 2004;27:540–63.PubMedCrossRefGoogle Scholar
  25. 25.
    Deer T, Krames ES, Hassenbusch SJ, et al. Polyanalgesic consensus conference 2007: recommendations of the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation. 2007;10:300–28.PubMedCrossRefGoogle Scholar
  26. 26.
    Deer TR, Smith HS, Cousins M, et al. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician. 2010;13:E175–213.PubMedGoogle Scholar
  27. 27.
    Krames E. Intrathecal infusional therapies for intractable pain: patient management guidelines. J Pain Symptom Manage. 1993;8(7):451–3.CrossRefGoogle Scholar
  28. 28.
    Coffey RJ, Owens ML, Broste SK, et al. Mortality associated with implantation and management of intrathecal opioid drug infusion systems to treat non-cancer pain. Anesthesiology. 2009;111(4):881–91.PubMedCrossRefGoogle Scholar
  29. 29.
    Deer T. A critical time for practice change in the pain treatment continuum: we need to reconsider the role of pumps in the patient care algorithm. Pain Med. 2010;11:987–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Hijazi Y, Bodonian C, Bolon M, Salord F, Boulieu R. Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury. Br J Anaesth. 2003;90(2):155–60.PubMedCrossRefGoogle Scholar
  31. 31.
    Correll GE, Maleki J, Gracely EJ, et al. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to CRPS. Pain Med. 2004;5:263–75.PubMedCrossRefGoogle Scholar
  32. 32.
    Goldberg ME, Domsky R, Scaringe D, et al. Multi-day low dose ketamine infusion for the treatment of CRPS. Pain Physician. 2005;8:175–9.PubMedGoogle Scholar
  33. 33.
    Kiefer RT, Roht P, Ploppa A, Altemeyer KH, Schwartzman RJ. Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract. 2007;7(2):147–50.PubMedCrossRefGoogle Scholar
  34. 34.
    Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med. 2008;9(8):1173–201.PubMedCrossRefGoogle Scholar
  35. 35.
    Kiefer RT, Rohr P, Ploppa A, et al. A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients. Pain Med. 2008;9(1):44–54.PubMedCrossRefGoogle Scholar
  36. 36.
    Drexel University College of Medicine. Double blind placebo controlled study of outpatient intravenous ketamine for the treatment of CRPS. Available at: http://clinicaltrials.gov/ct2/show/NCT00579085. Accessed 8 May 2009.
  37. 37.
    Getson P. Update on low-dose ketamine infusions. RSDSA Rev. 2009;22(2):8–9.Google Scholar
  38. 38.
    Noppers IM, Miesters M, Aarts LP, et al. Drug-induced liver injury following a repeated course of ketamine treatment for chronic pain in CRPS type 1 patients: a report of 3 cases. Pain. 2011;152(9):2173–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Kemler MA, Barendse GA, van Kleef M, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343:618–24.PubMedCrossRefGoogle Scholar
  40. 40.
    Stanton-Hicks M, Janig W, Hassenbusch SJ, et al. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain. 1995;3:127–33.CrossRefGoogle Scholar
  41. 41.
    Stanton-Hicks MD, Burton AW, Bruehl SP, et al. An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Pract. 2002;2:1–16.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Departments of Anesthesiology and Internal MedicineUCLALos AngelesUSA

Personalised recommendations